Peripherally‐active mu‐opioid receptor antagonists for constipation in critically ill patients receiving opioids: A case‐series and a systematic review and meta‐analysis of the literature

Naloxone Versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients

(2022) Ehsan A. Habeeb et al.   ANNALS OF PHARMACOTHERAPY

CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022

(2022) Deborah Dowell et al.   MMWR Recommendations and Reports

Efficacy of Naldemedine in the Management of Constipation in a Patient with Severe COVID-19 Receiving Mechanical Ventilation

(2021) Eri Hikita et al.   JOURNAL OF PALLIATIVE MEDICINE

Action Mode of Gut Motility, Fluid and Electrolyte Transport in Chronic Constipation

(2021) Qi Zhao et al.   Frontiers in Pharmacology

Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial

(2020) Parind B. Patel et al.   INTENSIVE CARE MEDICINE

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety

(2020) Joseph V Pergolizzi Jr et al.   Drug Design Development and Therapy

Naldemedine: A New Option for OIBD

(2020) Flaminia Coluzzi et al.   Journal of Pain Research

Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis

(2018) Pavit Luthra et al.   GUT

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain

(2018) Lynn R. Webster et al.   PAIN

Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

(2018) John W. Devlin et al.   CRITICAL CARE MEDICINE

Caring for Critically Ill Patients with the ABCDEF Bundle

(2018) Brenda T. Pun et al.   CRITICAL CARE MEDICINE

American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation

(2018) Seth D. Crockett et al.   GASTROENTEROLOGY

Pathophysiology and management of opioid-induced constipation: European expert consensus statement

(2018) Adam D Farmer et al.   United European Gastroenterology Journal

Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit

(2016) Cristian Merchan et al.   ANNALS OF PHARMACOTHERAPY

Bowel Disorders

(2016) Brian E. Lacy et al.   GASTROENTEROLOGY

Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction

(2015) Wojciech Leppert   Drug Design Development and Therapy

Use of Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Critical Care Patients

(2012) Sergio B. Sawh et al.   MAYO CLINIC PROCEEDINGS

A Multi-institutional Study Analyzing Effect of Prophylactic Medication for Prevention of Opioid-induced Gastrointestinal Dysfunction

(2011) Masashi Ishihara et al.   CLINICAL JOURNAL OF PAIN

The implementation of a bowel management protocol in an adult intensive care unit

(2011) Joanne McPeake et al.   Nursing in Critical Care

Constipation in long-term ventilated patients: Associated factors and impact on intensive care unit outcomes*

(2010) Arnaud Gacouin et al.   CRITICAL CARE MEDICINE

Constipation in intensive care unit: Incidence and risk factors

(2009) Antonio Paulo Nassar et al.   JOURNAL OF CRITICAL CARE

Reversal of Opioid-Induced Gastric Dysfunction in a Critically Ill Burn Patient After Methylnaltrexone

(2008) Michael Woo et al.   ANESTHESIA AND ANALGESIA

Opioid Side Effects — Mechanism-Based Therapy

(2008) Charles Berde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Opioid-Induced Bowel Dysfunction

(2007) Jay Thomas   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT